CIK 0001274737
- Non-accelerated filer
- Smaller reporting company
EXAGEN INC.
Sign in to watch- Ticker
- XGN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 760-560-1501
- Business address
- 1261 LIBERTY WAY, VISTA, CA, 92081
- Former names
- EXAGEN DIAGNOSTICS INC
- Open-market buys, last 90 days
- $568,660
- in 3 filings
- Open-market sales, last 90 days
- $1,233,534
- in 4 filings
Net −$664,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-16 | ABALLI JOHN President and CEO | Sale | −34,294 | $7.87 | $270K | 805,540 |
| 2026-03-12 | ABALLI JOHN President and CEO | Grant or award | +150,000 | 839,834 | ||
| 2026-03-12 | ABALLI JOHN President and CEO | Grant or award · Stock Option(right to buy) | +100,000 | $3.16 | $316K | 175,000 |
| 2026-03-03 | ABALLI JOHN President and CEO | Sale | −15,698 | $3.62 | $57K | 687,299 |
| 2026-03-03 | ABALLI JOHN President and CEO | Grant or award | +2,535 | $3.08 | $8K | 689,834 |
| 2026-02-24 | ABALLI JOHN President and CEO | Sale | −11,430 | $3.61 | $41K | 702,997 |
| 2025-10-16 | ABALLI JOHN President and CEO | Sale | −31,787 | $11.82 | $376K | 714,427 |
| 2025-02-28 | ABALLI JOHN President and CEO | Grant or award | +8,621 | $2.47 | $21K | 746,214 |
| 2025-02-21 | ABALLI JOHN President and CEO | Grant or award | +112,500 | 737,593 | ||
| 2025-02-21 | ABALLI JOHN President and CEO | Grant or award · Stock Option(right to buy) | +75,000 | $3.58 | $269K | 75,000 |
| 2024-11-14 | ABALLI JOHN President and CEO | Purchase | +24,305 | $2.81 | $68K | 689,799 |
| 2024-05-16 | ABALLI JOHN President and CEO | Purchase | +40,401 | $1.92 | $78K | 40,401 |
| 2024-02-29 | ABALLI JOHN President and CEO | Grant or award | +9,804 | $1.91 | $19K | 600,788 |
| 2024-02-20 | ABALLI JOHN President and CEO | Grant or award | +175,000 | 590,984 | ||
| 2023-10-17 | ABALLI JOHN President and CEO | Sale | −33,819 | $1.75 | $59K | 415,984 |
| 2023-08-31 | ABALLI JOHN President and CEO | Grant or award | +9,803 | $2.14 | $21K | 449,803 |
| 2022-12-08 | ABALLI JOHN President and CEO | Purchase | +90,000 | $2.68 | $241K | 440,000 |
| 2022-10-16 | ABALLI JOHN President and CEO | Grant or award | +350,000 | 350,000 |
Page 1 of 1 · 18 trades